3-(2,2,2-trimethylhydrazine)propionate has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anisimov, VN; Belitskiĭ, GA; Kalvinysh, IIa; Khovanova, EM; Tolcheev, IuD; Ugvinenko, EG | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Adenocarcinoma
Article | Year |
---|---|
[Absence of mutagenic and carcinogenic properties in Mildronate].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Carcinogens; Drosophila melanogaster; Female; Mammary Neoplasms, Experimental; Methylhydrazines; Mice; Mice, Inbred Strains; Mutagens | 1999 |